THE STRONGMAN IMMUNE SYSTEM: INFLAMMATION, DEFENSE AND ADAPTATION | Episode 1: The Immune System and Strength Exertion: Host Defense and Muscular Activity

The immune system and strength exertion: from the image of defense to the biology of adaptation

A strongman lifting an Atlas stone recruits much more than muscle fibers, energy stores, and neural circuits. The body simultaneously adjusts blood flow, hormonal secretion, temperature, immune-cell distribution, and communication between tissues. These adjustments occur in an organism whose immediate priority is to generate substantial force while maintaining homeostasis, a dynamic form of internal stability. Saying that the immune system responds to training does not mean that the athlete has caught an infection or that every cellular defender has been uniformly switched on. It means that coordinated changes take place, sometimes measurable in blood and sometimes only in tissues, reflecting mobilization, signaling, redistribution, or repair. This diversity explains why a striking laboratory result may still be insufficient for a clinical conclusion. A higher white-blood-cell count after a demanding event does not prove improved immunity; a subsequent decline in circulating lymphocytes does not demonstrate that protection has vanished. Understanding the relationship between host defense and muscular activity requires asking what changes, where it changes, how long it lasts, and whether the change affects health [1–3].

This series examines the immune system as a network for surveillance, communication, and regulation, not as a mysterious reserve of immunity that is filled and emptied by each workout. The first distinction is between innate immunity, which responds rapidly by recognizing broad classes of danger signals, and adaptive immunity, which can develop antigen specificity and immunological memory. That distinction is useful for teaching, but these branches cooperate continuously: antigen-presenting cells, cytokines, complement pathways, and lymphocytes communicate in both directions. Less visually dramatic components are just as essential: skin, respiratory and intestinal epithelia, mucus, local chemical defenses, and the microbiota. A pathogen may be stopped long before it encounters a circulating lymphocyte. Consequently, immune health cannot be reduced to a complete blood count, the concentration of one interleukin, or the absence of symptoms over a particular week. Our interpretation will draw upon exercise immunology while repeatedly distinguishing evidence obtained from resistance training from findings derived from prolonged running or sedentary populations [2,4].

Strongman is a strength discipline with features that resist classification under a single experimental protocol. Three repetitions of log press may heavily challenge the neuromuscular system over several dozen seconds; a yoke carry requires locomotion under major axial loading, coordination, and increased ventilation; repeated sandbag loading combines difficult grips, trunk flexion, locomotion, and short recovery periods; a multi-event contest adds psychological pressure, social exposure, dietary disruption, and travel. Thus, strength exertion is not one biological treatment. Absolute load, percentage of maximal capacity, contraction duration, total volume, eccentric components, and rest intervals may elicit different physiological profiles. Most research does not test professional strongman athletes using stones, logs, or pulled trucks. Findings from conventional weight-training studies can provide reasonable working hypotheses, but should never be presented as direct observations for every strongman event [4,5].

The objective of this introduction is not to identify a workout that guarantees to boost immunity. That phrase is commercially attractive but scientifically too vague. Researchers can investigate immune-cell numbers or phenotypes, phagocytic activity, cytokine secretion, and responses to vaccination; separately, they can measure confirmed infections and days of training lost. Several biological steps and numerous confounding variables often lie between a biomarker and a clinical outcome. An athlete might display a transient rise in interleukin-6 after a session and experience no symptoms; another might report a sore throat caused by allergy or dry air rather than infection. Neither observation can be translated directly into good or bad immunity. Rigorous terminology benefits non-specialists, too: it helps explain why apparently conflicting scientific reports may actually concern distinct processes measured at different times [1,3,6].

What kind of system is immunity, and what do we see in blood?

Leukocytes are a family, not a homogeneous unit. Neutrophils can respond rapidly to inflammatory signals and engage in phagocytosis; circulating monocytes can enter tissues and differentiate into cells with diverse functions; natural killer cells can recognize selected infected or transformed cells without the same antigen-specific priming used by T lymphocytes; B lymphocytes can make antibodies after appropriate activation; and T lymphocytes include effector, memory, and regulatory populations. These labels conceal subpopulations with different receptors, locations, and tasks. When a laboratory reports lymphocytes, its single number combines cells whose functions cannot be inferred from that figure alone. Moreover, when their concentration in a blood sample rises, it does not automatically mean that the body has instantly produced new cells. Blood is a transport route between compartments; flow, stress hormones, and endothelial adhesion can rapidly change which cells are represented there. A complete blood count obtained immediately after a competition is therefore not equivalent to one collected on a quiet morning after rest [1,2,7].

Immune processes operate on multiple timescales. Autonomic and hemodynamic changes can begin within seconds; catecholamine signaling and the distribution of some leukocytes change within minutes; inflammatory communication and tissue metabolism evolve over hours; processes associated with localized repair unfold across days; and training adaptations require repeated exposures over weeks or months. No single temporal snapshot describes the whole story. Investigators collecting blood before exercise, immediately afterwards, and two hours later will see something different from colleagues measuring only at 24 hours. Likewise, a comparison between athletes with markedly different training histories may confuse the response to today's session with adaptation acquired beforehand. The problem becomes harder still when samples are obtained at different hours, after different meals, or during dehydration. Physiological interpretation requires chronology and context, not merely mechanical comparison with a laboratory reference interval [2,4,7].

The word activation requires care in modern immunology. Activation of an intracellular signaling pathway such as NF-κB is not synonymous with active infection, pathological inflammation, or an overall improvement in host defense. NF-κB refers to a family of transcription factors that regulate the expression of many genes, including genes involved in inflammation, cell survival, and stress responses. A 2022 systematic review of resistance exercise reported activation of immune signaling pathways after acute sessions and functional changes after training interventions. However, its authors emphasized heterogeneity across experiments, age-related differences, and uncertainty surrounding some measures of lymphocyte proliferation. A paper demonstrating change in a molecular marker has not automatically demonstrated fewer respiratory infections among strongman athletes. That stronger claim requires a different study design and different outcome measurements [4].

Immune activity is not always better when there is simply more of it. Excessive or misdirected responses may injure tissues, produce allergic manifestations, or contribute to autoimmune pathology. An inadequate response may delay pathogen clearance, whereas an excessive one may damage the very tissue the system is supposed to defend. The balance among recognition, intervention, and resolution matters more than the isolated strength of one signal. This is especially relevant in sport: short-lived rises in selected mediators after training can be compatible with adaptation, whereas persistently elevated baseline inflammatory indicators raise different questions about metabolism, comorbidities, or prolonged stress. Homeostasis does not mean the complete absence of variation; it refers to the body's capacity to regulate variation according to demand. A well-regulated immune system can respond rapidly and then move back toward functional equilibrium [3,5,8].

From neural command to cellular redistribution

During a demanding lift, sympathetic nervous system activity and circulating catecholamines may increase. Epinephrine and norepinephrine act on receptors expressed by numerous cell types, including leukocytes and vascular cells. These signals contribute to the rapid mobilization of certain immune subsets into blood, alongside changes in cardiac output, perfusion of active muscles, and shear forces along vessel walls. Exercise studies often describe particularly pronounced mobilization of natural killer cells and some differentiated T-cell populations during intense effort. Not every cell type behaves identically, and every strongman event should not be assumed to reproduce the exact kinetics reported in cyclists or runners. The central principle nevertheless holds: the bloodstream contains a mobile fraction of a system spread throughout the body, and a change in that fraction can reflect trafficking rather than the creation or destruction of immune cells [7,9].

After exercise, some lymphocyte populations can temporarily drop below their pre-session circulating concentrations. Historically, this observation was frequently described as an open window of immune vulnerability. The interpretation became controversial because the relative disappearance of cells from peripheral blood tells us neither where they went nor whether immune function deteriorated. In 2018, Campbell and Turner argued that cellular redistribution into other compartments might indicate enhanced immune surveillance rather than a collapse of defense. A debate published in 2020 nevertheless showed that the independent contribution of exceptionally demanding exercise to infection risk remains incompletely settled. Consequently, it is unwarranted to treat the old hypothesis as a universal law, but equally simplistic to claim that all extreme exercise is free of potential risks. Progress requires distinguishing the measurement itself from the biological story assigned to it [1,3].

Glucocorticoids, particularly cortisol, participate in stress responses and the regulation of metabolism and inflammation. Their secretion varies across the day and is affected by sleep, eating patterns, perceived stress, and exercise characteristics; a single result therefore has limited meaning without context. In sporting culture, cortisol has sometimes become shorthand for catabolism and supposedly inevitable immune suppression. This picture is incomplete. Glucocorticoid action depends on concentration, duration, receptor sensitivity, and tissue condition, and includes physiological regulation of inflammatory responses. A transient rise around exercise is not a diagnosis of hypercortisolism or immunodeficiency. Acute and chronic stress can influence immune processes differently, an issue examined by Dhabhar in an influential synthesis of adaptive and maladaptive responses to stress. For athletes, the useful question is not whether they can abolish stress altogether, but whether their exposure, available resources, and recovery form a sustainable whole [8].

Viewed from the gym, leukocyte mobilization may look like a by-product of muscular strain, but the mechanism is more general. The autonomic nervous system connects the brain to the spleen, bone marrow, blood vessels, and lymphoid organs. Adrenergic receptors do not transmit a single universal instruction: responses vary with receptor subtype, mediator concentration, and cellular phenotype. Some cells are particularly responsive to catecholaminergic stimulation and therefore appear rapidly in blood as circulatory demands increase. This traffic probably supports several purposes, including redistribution of immune surveillance, although functional evidence is less direct than observations of cell counts. The practical lesson for coaches is neither that adrenaline cures disease nor that it causes it, but that exertion produces an integrated response that cannot be interpreted separately from circulation and neuroendocrine physiology [7,9].

A crucial distinction is that between absolute cell counts and percentages. A lower lymphocyte percentage does not necessarily imply that the absolute number of lymphocytes has declined; neutrophils may simply constitute a larger fraction of the total leukocyte population. Dehydration changes plasma volume and can concentrate some measurements, whereas fluid intake and recovery may subsequently change measured concentrations. Comparing two workouts therefore requires at least some standardization of sampling time, previous exertion, food intake, symptoms, and time since the final set. Even under good conditions, the complete blood count remains a contextual clinical tool rather than an immunity score. Laboratory reference intervals describe population distributions; they do not directly predict whether an athlete will develop a respiratory infection at the next competition.

Leukocyte trafficking is not the only route through which physical activity interacts with immunity. Muscle contraction changes energy-substrate availability, local oxygen consumption, redox balance, and expression of genes related to metabolism and stress. Glucose, fatty acids, and lactate are not merely muscular fuels; they also shape the environment in which immune cells function. Immunometabolism examines the links between energy availability, biochemical pathway use, and the capacity of cells to execute particular tasks. Yet detecting pathway activation after exercise does not establish that the net outcome is greater clinical protection. Relationships may depend on tissue, dose, timing, and baseline state. In strongman, energy demands differ greatly between a maximal single and a repeated-event medley, so there is little reason to presume a single immunometabolic fingerprint.

This molecular perspective helps explain why two sessions with identical total tonnage need not be biologically equivalent. Ten isolated lifts with generous rests may have a very different work-to-rest ratio from timed loading repetitions. Exercises recruit differing amounts of muscle tissue, challenge muscles at different lengths, and create varying degrees of mechanical deformation. Blood measurements may reflect these distinctions. Accordingly, prescribing an optimal immune volume based solely on kilograms lifted would not be scientific. Percentage of one-repetition maximum also fails to capture exertion duration, density, environmental temperature, or ventilatory stress. Convincing research must describe its protocol precisely enough for replication and report not just statistical changes, but the magnitude and uncertainty of the estimated effects.

Contracting muscle, cytokines, and communication among tissues

Skeletal muscle is best known for its mechanical function, but it also operates as a signaling organ. Muscle fibers can produce and release molecules with local or distant effects, often grouped under the broad term myokines. This concept does not imply that every cytokine detected in blood after exercise originates from muscle. Numerous tissues, including adipose tissue and immune cells, can contribute to circulating concentrations. Interleukin-6, or IL-6, illustrates the complexity. In some clinical contexts it participates in disease-associated inflammation; around muscular contraction, its increase can be associated with the regulation of fuel use and other mediators. Pedersen and Febbraio played an important role in developing the muscle-as-endocrine-organ framework. Yet neither the label myokine nor the name of one interleukin allows its biological function to be inferred automatically from a solitary value [5].

A useful test of interpretation is to ask what elevated IL-6 immediately after training actually means. A professional answer begins by noting that the assay measures concentration, not precise tissue origin or the complete set of actions performed by the molecule. Exercise may induce temporary changes through muscular and immune mechanisms, with the response influenced by active muscle mass, session characteristics, and sampling time. A 2024 meta-analysis of myokines following resistance exercise identified immediate effects on IL-6 and IL-1ra, with different results for other molecules. The authors did not identify statistically significant moderators across their analyses, but this does not prove biological relationships are absent; available studies may be too few or too heterogeneous to detect them. The warranted conclusion is that measurable signaling responses occur, not that pathological inflammation has been diagnosed or that immunity has been fortified [10].

IL-1ra, the interleukin-1 receptor antagonist, is among the molecules involved in limiting certain inflammatory signals. Its name illustrates why inflammatory biology cannot be reduced to a contest between good and bad substances. Some mediators initiate or amplify cell recruitment, others constrain its intensity, and the same molecule can play different roles depending on compartment and timing. An effective response includes both initiation and resolution. Measuring only the peak of a cytokine resembles evaluating a long process from a single frame. Meta-analyses estimate average effects across included studies; they do not describe every individual athlete and certainly do not establish an optimal concentration of each mediator for a particular strongman event [10].

Tumor necrosis factor alpha, abbreviated TNF-α, is often presented to the public as an exclusively negative marker. In reality, it participates in immune communication, antimicrobial defense, and inflammatory processes that become problematic under particular circumstances. A meta-analysis of randomized resistance-training trials found a mean reduction in TNF-α following interventions, without significant overall changes in every assessed marker, including IL-6 and C-reactive protein. Thus, even long-term responses cannot be summarized as all cytokines going down. Population differences, methodology, baseline condition, and program design are relevant. Improvement in one peripheral biomarker is also not proof of reduced infection risk. The body does not optimize a single molecule but many interacting networks with feedback and compensatory relationships [11].

Within an athlete's body, muscle cells communicate through more than classical cytokines. Exercise can alter the release of peptides, metabolites, and extracellular vesicles carrying molecular cargo between cells. Research on exerkines, a broad term for exercise-associated mediators, is developing rapidly. A plausible experimental mechanism, however, should not prematurely be transformed into a practical method for manipulating immunity. Many studies use cell systems, animals, or small groups of volunteers. For elite athletes, variation in effort and repeated exposure complicate extrapolation. We can state confidently that active muscle participates in systemic communication and that this communication provides a genuine biological link between exertion and the immune environment [5,10].

Useful inflammation is not the same as inflammatory disease

Inflammation is a biological program for detecting and responding to disruption, not merely a symptom of disease. Following unfamiliar muscular work, especially work involving substantial eccentric contractions, ultrastructural changes, temporary strength loss, swelling, and soreness may occur. These phenomena feature in the exercise-induced muscle damage literature, which describes interactions among mechanical stress, local signals, and cell recruitment. Delayed-onset muscle soreness, however, is neither an accurate measure of lesion severity nor a direct indicator of training quality. An adapted athlete may progress with little soreness, while another who abruptly resumes an unfamiliar movement may experience pronounced discomfort despite poor programming. Physiological reactions should be interpreted relative to function, symptoms, loading history, and evolution over time, rather than celebrated as compulsory evidence of progress [6].

During tissue repair, immune cells help remove cellular debris and coordinate the environment in which muscle progenitors and other local populations operate. Macrophages, for instance, do not perform identical functions at every stage. The popular picture of a strict succession from pro-inflammatory to anti-inflammatory macrophages oversimplifies cellular plasticity and local tissue diversity. Repair involves overlapping signals, and its outcome depends on injury severity, blood supply, and the organism's wider response. A practical limit follows: indiscriminately suppressing every inflammatory signal after every workout is not necessarily an optimal strategy, yet that observation does not justify ignoring abnormal pain or avoiding medical assessment. Temporary discomfort and symptoms suggesting significant injury are different matters [6].

Another potential confounder is the low-grade inflammation associated with certain metabolic conditions. Adipose tissue is endocrinologically and immunologically active; its distribution, insulin sensitivity, sleep quality, and existing disease may influence circulating biomarkers. For a particularly massive athlete, body weight alone cannot be interpreted either as an advantage or as proof of a particular inflammatory state. Body composition, cardiometabolic profile, and medical history add essential information. If baseline biomarkers shift across a season, attributing the change entirely to one day of yoke carries or deadlifts neglects these variables. Good research must control pre-existing health and group differences where possible; otherwise, it risks comparing unlike biological factors under the common label of training.

An acute rise in a mediator and a lower baseline value after several months of training are not contradictory findings. The first may describe the immediate response to a stressor; the second may reflect longer-term regulation of the metabolic and inflammatory environment. Studies of habitual physical activity frequently report associations with metabolic health and certain aspects of immune regulation, but effect size and generalizability depend on population and outcome. Strength training contributes to health through several pathways, not all of which can be statistically separated from changes in body composition or other behaviors. Adaptation calls for a longitudinal perspective, whereas diagnosis calls for clinical criteria; these are not the same question [2,4,11].

Contact barriers: breathing, mucosa, and the training environment

Discussions of athletes' immunity often focus on circulating cells even though infectious agents commonly first encounter epithelial surfaces. Respiratory epithelium is a physical and biochemical barrier, while mucus and mucociliary transport help remove inhaled particles. Epithelial cells are not passive bricks; they can recognize microbial signals and release mediators that organize local responses. Respiratory exposure depends on ventilation, air quality, crowding, and patterns of social contact. An athlete training in a crowded gym may inhale aerosols released by an infected person regardless of the weight lifted that evening. Infection risk therefore requires a distinction between hypothetical biological susceptibility and the actual opportunity for exposure. Without encountering a pathogen, post-exercise changes in biomarkers do not themselves create a viral infection [2,12].

Secretory immunoglobulin A, often abbreviated sIgA, contributes to mucosal protection through mechanisms that include limiting pathogen interactions with epithelial surfaces. Sports researchers have investigated salivary sIgA concentration and secretion rate as potential indicators of stress and respiratory illness risk. Saliva, however, is a variable biological specimen: salivary flow, time of day, hydration, oral hygiene, infections, and sampling procedures influence its measurement. One low value does not establish immunodeficiency or justify a medical label. Concentration and secretion rate, in particular, are distinct parameters and should not be treated as interchangeable. The sIgA discussion is valuable precisely because it exposes the danger of premature interpretation: a local marker may be useful in research without becoming a validated predictive clinical instrument for every individual athlete [1–3].

Increased ventilation during demanding events can change exposure to cold, dry, or polluted air. Under some conditions, airway irritation produces coughing, dryness, or discomfort without an infectious cause. Allergic rhinitis, exercise-related asthma, and other respiratory conditions are relevant in athletes and require differential diagnosis. Not every symptom occurring after competition proves that the immune system has been weakened. The International Olympic Committee consensus on acute respiratory illness emphasizes careful clinical evaluation and the distinction between infectious and non-infectious causes. Strongman athletes may compete in industrial venues, outdoors, or in crowded halls, making environmental conditions worth documenting alongside loads lifted. Temporal association between a deadlift event and a sore throat does not demonstrate a causal relationship [12].

Local defense is also influenced by ordinary behaviors: hand hygiene, avoiding shared drinking containers, cleaning frequently touched surfaces, and limiting close contacts during contagious illness. These practices do not replace training; they address another link in the epidemiological chain, exposure. At an international competition, athletes may spend hours in coaches, aircraft, changing rooms, hotels, or official weigh-in areas. If multiple cases of respiratory illness occur afterwards, demanding training is only one potential variable. Without information on who was exposed, who was already symptomatic, which pathogen circulated, and when each illness began, responsibility cannot be assigned to a particular hormonal mechanism. Practical prevention starts by recognizing concrete modifiable risks without undermining athletic preparation [2,3,12].

The intestinal mucosa is another major interface between the body and its environment. The epithelial barrier, local immunity, and microbial communities form a dynamic system influenced by food, medication, illness, and individual characteristics. Studies of prolonged exertion have examined intestinal permeability and gastrointestinal disorders, but not every finding should be transferred automatically to strength-training sessions. Likewise, an athlete experiencing highly variable energy intake, long journeys, and improvised eating patterns may develop digestive symptoms without immune deficiency being the main explanation. Interpretation should remain contextual and clinical. Persistent gastrointestinal problems, fever, blood in the stool, or important dehydration require medical attention, not improvised experiments with supplements marketed as microbiome fixes.

Infection risk: what we know, what correlates, and what remains unproven

A substantial research literature reports that habitual physical activity is associated with broad health benefits, including some elements of immune regulation. Meanwhile, groups of high-performance athletes can experience illness episodes during intensive preparation and competition. These observations do not amount to two mutually exclusive universal laws. Active people and elite athletes differ from sedentary populations in age, body composition, behavior, travel, social exposures, and access to medical monitoring. When a survey reports more respiratory symptoms in a high-training-volume group, we must ask who was included and how illness episodes were defined. Statistical association cannot establish that training caused infection, particularly when actual exposure to pathogens has not been measured [2,3].

Acute respiratory illness encompasses more than laboratory-confirmed viral infections. An athlete may report congestion, nasal discharge, cough, or sore throat due to infection, allergy, irritation, or other mechanisms. Combining all these events means that the study has not specifically measured infection. Furthermore, a diagnosis supported by pathogen testing and a retrospective symptom questionnaire do not offer equivalent specificity. In epidemiology, case definition matters as much as case counting. The Olympic consensus on respiratory infections gives attention to clinical syndromes and systemic signs. Strongman research would benefit from separate reporting of symptoms, diagnosed episodes, and days of training actually lost, so that clinically meaningful disease is not conflated with ordinary post-competition fatigue [12].

The traditional J-shaped curve hypothesis proposes lower infection risk with moderate activity and potentially higher risk under extreme workloads. It has played a historical role in structuring research questions, but a geometric curve is not an immutable natural law. Relationships between volume and infection may differ according to population and measurement quality; athletes who tolerate large volumes may be selected through health, genetics, and experience. Even the meaning of extreme is contextual: a dose tolerated by an adapted athlete may be unfamiliar to a novice. Modern interpretations caution against categorical claims of suppression based only on circulating leukocyte data. Nevertheless, protecting sleep, nutrition, and general health during demanding training remains sensible even when infection cannot be attributed to a single exposure [1–3].

Sound causal reasoning begins with chronology. An athlete who becomes ill after a competition may have encountered the pathogen before the first event, during travel, or in preceding days. Incubation periods differ across infections, and symptom onset need not coincide with exposure. If a symptom begins 24 hours after a contest, the number of repetitions performed cannot determine its cause. Isolating exertion effects would require prospective monitoring of exposure, symptoms, clinical tests, and training loads. Even then, perceived stress and social-contact conditions are difficult to control. Rigorous science does not insist on one neat story when the data support multiple plausible explanations.

Another error is to conclude that an athlete who has never caught a cold after competition has superior immunity because of a particular training method. The absence of a recent episode tells us too little about future probability, exposure, or immune history. Conversely, one viral infection does not demonstrate that training is ineffective or that the athlete has developed overtraining syndrome. Individual variation and epidemiological chance play genuine roles. Sample size, observation duration, and precise outcome definitions are essential for distinguishing stable effects from ordinary fluctuation. In a small team, a change from two to four athletes reporting symptoms may look like a dramatic doubling without supporting a robust conclusion. Proportions therefore need confidence intervals and consideration of measurement error.

Competitive stress is more than the weight on the bar

Strongman competition takes place amid evaluation pressure, spectators, time limits, and uncertainty about event demands. These factors may change autonomic activation and perceived effort before the first repetition. Competition is not an emotionally sterile laboratory: athletes may sleep differently before starting, change meals, travel extensively, and disrupt their usual routines. Biological effects of these circumstances do not make every emotion harmful. Short-lived activation may support the mobilization of resources and performance, while difficulties are more likely when demands are repeated without sufficient resources or when illness and external stressors intervene. Dhabhar distinguishes potentially adaptive effects of brief stress from unfavorable effects of chronic exposure. In strongman, that distinction helps explain why a competitive peak and several weeks of insufficient sleep should not be treated as the same stimulus [8].

Cross-border travel adds variables that complicate any claim about the immune effects of competition. Hours in enclosed spaces, dry transport air, sleep loss, changing routines, altered meals, and encounters with unfamiliar people may coincide with maximal exertion. Some variables might influence biological susceptibility, others increase only the chance of contact with an infectious agent, and still others alter symptom reporting. An analysis limited to event counts that ignores a twenty-hour journey misattributes a complex effect. A useful journal might note travel duration, approximate sleep, symptoms, and relevant contacts without turning every observation into a diagnosis. The aim is to identify modifiable patterns, not cultivate anxiety over each physiological variation.

At a multi-day competition, exposures accumulate differently from a single event. An athlete may perform a demanding event, spend hours in the venue, return to a hotel, and begin again the following day. Food, hydration, and sleep can become logistically harder to organize. At the same time, the body does not stop defending itself between events, and successive competition days do not justify the claim that immunity falls in a straight line. Responses remain dynamic and depend on intensity, recovery, and circumstances. For short-term consequences, tracking symptoms before, during, and after a contest is more informative than assumptions based exclusively on perceived fatigue. If fever or systemic illness develops, medical assessment takes priority over proving toughness through continued exertion [12].

An experienced athlete may preserve impressive mechanical performance despite transient biological changes. That does not make a personal record a test of immune function. Force produced in an event depends on technique, coordination, motivation, muscular adaptation, previous preparation, and numerous other factors. Winning a competition cannot replace clinical evaluation, just as a disappointing performance on a difficult day cannot confirm systemic inflammation. This distinction matters because the tendency to explain every outcome through one mechanism produces circular stories: the athlete won, therefore immunity was excellent; the athlete lost, therefore inflammation sabotaged performance. Neither claim is supported without independent measurements.

From a public-health perspective, social environments are impossible to ignore. Contagion does not depend on athletic courage, and a pathogen is indifferent to a deadlift record. The interaction of exposure and susceptibility determines the probability of infection. A team recognizing this distinction can discuss symptoms openly, avoid sharing bottles, and arrange practical alternatives when a member becomes ill. Such conduct protects athletes and colleagues without treating strength training itself as an inevitable threat. Applied immunology should lead to proportionate, realistic decisions rather than elaborate rituals or promises of invulnerability.

What do available studies tell us about weight training?

A strength program consists of different stimuli that cannot be compressed into one number. Relative intensity generally describes load in relation to maximum capacity, but volume, session density, eccentric work, and rest periods can change total stress. From an immunological standpoint, we do not know that two workouts at the same percentage of one-repetition maximum will produce identical outcomes if one involves many repetitions near failure and the other isolated singles with long rests. Resistance-exercise studies document acute cellular and mediator responses, but protocol characteristics matter for interpretation. Some interventions also involve untrained or older individuals rather than experienced competitive athletes. A systematic review by Salimans and colleagues included 30 intervention studies, an informative but heterogeneous evidence base. Conclusions regarding selected immune functions must remain tied to studied populations rather than being converted into exact prescriptions for a strongman medley [4].

Proximity to muscular failure offers another example of a variable poorly captured by absolute weight. Ten repetitions completed with substantial reserve may differ from a set ending at the last possible repetition. Perceived exertion, metabolite accumulation, and muscle recruitment can vary, yet no quantified immune advantage or loss can be derived from these differences alone. Autoregulation tools such as perceived exertion ratings or repetitions in reserve usefully describe session difficulty for programming, without being immunological tests. When discussing possible risk, consider how frequently very demanding workouts occur, whether they are consecutive, and the athlete's general condition. One heavy session within a balanced program is not equivalent to several weeks during which sleep, eating patterns, and recovery capacity progressively deteriorate.

Strongman events also introduce variable metabolic demands. A maximal lift performed in seconds is energetically different from a timed circuit involving carrying implements, loading bags, and repeated actions. However, a strict division into anaerobic and aerobic effort is only a teaching simplification: energy pathways overlap, even though their relative contributions differ. In a longer event, greater ventilation, body temperature, and cardiovascular challenge may become relevant to systemic responses. It is insufficient to label every event strength and therefore assume immunological equivalence. Research protocols should report activity duration, rests, number of attempts, and intensity measures in a format that permits defensible comparisons between sessions.

The eccentric component of contraction deserves separate consideration. When muscle produces force while lengthening, its mechanical demands may differ from those of concentric contraction. Unfamiliar eccentric exercise may temporarily reduce muscle function and elicit complex local responses, as described in the exercise-induced muscle damage literature. Individual strongman repetitions, however, combine different phases and cannot always be classified simply. Controlled implement lowering, stabilization under load, and transitions between phases may involve distinctive local demands. When investigating post-exercise inflammation, we should describe those components rather than assume implement mass alone explains the entire response [6].

Rest intervals modify not only execution quality but also session duration and metabolic context. Very short rests may increase fatigue for a given workload, while longer rests can help preserve performance at heavier loads. There is nevertheless no validated rule assigning a specific immune benefit to a particular rest interval in strongman athletes. Studies measuring hormones or cytokines immediately after a workout cannot substitute for evidence on clinical infections. Rest prescription should first reflect the goal of strength, technique, or exertion tolerance. Immune implications belong within the wider management of training stress rather than providing a reason to compromise safety and repetition quality in pursuit of hypothetical immune stimulation.

Regular training can produce biological adaptations distinct from the responses to one acute session. Studies of immune-cell function after resistance-training programs suggest favorable changes in selected measures, including neutrophil phagocytic activity and certain redox-protection mechanisms. Yet the 2022 systematic review noted that a single session affected natural killer cell activity differently in younger and older adults. These contrasts are informative: a uniform human immune response does not exist. An adaptation detected in older participants cannot be quantified automatically in a young Open-class competitor, and a laboratory effect carries limited meaning without clinical context [4].

Individual variability is not disposable noise

Age, sex, infection history, vaccination, medical conditions, sleep, nutrition, and previous exposure to exercise may influence observed immune responses. Some differences originate in biology, others in how participants are recruited and measured. Comparing a 140-kilogram competitive lifter with average sedentary volunteers can be illustrative but is not strongman-specific evidence. Participant characterization is an interpretive necessity, not an editorial formality. Experience often changes tolerance of familiar tasks, while relationships between mechanical stress and systemic responses may vary in magnitude. Yet we lack adequate information to construct a personalized ranking of strongman immune resilience from body mass and personal records.

Training history also shapes the subjective experience of exertion. A technically familiar event may be executed more efficiently and with fewer failed attempts than the same event performed by a beginner. This can alter cumulative demands without any change in implement mass. However, a difference in motor competence does not automatically translate into a particular immune-cell profile. Studies comparing experienced and novice participants must account for different absolute strength capabilities as well. In strongman, the most adapted athletes may create mechanical demands that would be impossible for ordinary laboratory participants. Thus, adapted must not be confused with always lightly challenged, and experience must not become a universal explanation for the presence or absence of infections.

Differences involving sex and age should not be treated as simple binary labels determining outcomes. Hormonal patterns, body-composition distribution, reproductive history, and other variables can influence certain immune mechanisms, but within-group variability remains substantial. Small studies may confound demographic differences with protocol or fitness differences. An honest article states limits to generalization instead of assigning every man or woman a particular level of immunity. Strongwoman and Strongman include athletes with highly diverse profiles; evidence-based coaching should respect this diversity and avoid immunological prescriptions mechanically derived from category, sex, or records.

Sleep is one variable that can explain differences between otherwise similar sessions. Insufficient duration, fragmented sleep, irregular timing, and sleep-related breathing disorders can influence health and recovery. However, one imperfect night before competition does not mean an athlete has instantly developed immunodeficiency. Research examines both acute sleep restriction and chronic patterns, with conclusions depending on the measured outcome. In a larger athlete, marked sleepiness, substantial snoring, or breathing pauses described by a partner warrant clinical evaluation, because these matters extend well beyond muscular performance. Discussions of immunity should not obscure problems that may need a separate diagnosis.

Nutrition adds another dimension: energy availability, protein and micronutrient intake, digestive tolerance, and overall diet quality. There is no evidence that a capsule promising guaranteed immune protection can replace these fundamentals. Prolonged underfeeding and inadequate intake can compromise multiple physiological functions; conversely, indiscriminately increasing intake above requirements does not necessarily confer extra protection. Strength athletes with high body mass and energy expenditure may face logistical difficulties, but that does not make every hypercaloric strategy immunologically optimal. Nutritional interventions should be individualized, and targeted supplementation makes sense when an actual indication, deficiency, or appropriate clinical context exists [2].

Alcohol consumption, smoking, occupational irritants, and certain medications can affect respiratory health or immune processes. Strength sports also require consideration of performance-modifying pharmacological substances, whose endocrine, hematological, cardiovascular, and metabolic effects may complicate laboratory interpretation. General evidence regarding exercise benefits is not evidence that these substances are safe. Without medical review and a complete medication history, attributing abnormal results exclusively to training stress is unreliable. This article does not offer administration protocols and does not use immunology to justify avoidable pharmaceutical exposure.

An existing chronic illness, recent infection, or medical intervention may influence an individual's markers more strongly than the last gym session. Test results should be interpreted alongside clinical history and signs. An athlete with fever, pronounced fatigue, and enlarged lymph nodes should not invoke leukocyte trafficking theory to minimize symptoms. Likewise, a persistently abnormal blood count deserves interpretation by a clinician rather than being normalized with the assertion that all strongmen are inflamed. Exercise research describes average tendencies; medicine cares for particular people with potentially distinct disorders.

Selection effects: who becomes an elite athlete?

One subtle challenge in sports research is participant selection. Athletes who withstand years of intensive preparation are the people who could continue, whereas those who withdrew because of illness, injury, or life constraints may be absent from a sample. Comparing an elite group with the general population may overestimate training's protective effects or underestimate risks for people unable to tolerate the same demands. This is a form of selection bias that matters in observational research. An exceptional athlete is not statistical proof of the universal effects of that athlete's method. Their biography may supply hypotheses, examples, and interesting practical questions, but cannot replace a comparison group and transparent methodology.

Reporting bias may pull in the opposite direction. High-performance athletes are often monitored more closely than ordinary adults, so minor illnesses may be documented more frequently. Sometimes athletes conceal symptoms to avoid losing selection or competition opportunities, resulting in underreporting. These opposing mechanisms explain why statistics across different groups should be compared cautiously. More medical consultations do not automatically mean a biologically higher infection rate, while fewer declared symptoms do not prove perfect health. Good research seeks harmonized definitions and collection procedures, prospective follow-up, and explicit acknowledgment of unresolved uncertainty.

In practice, the distinction between resistance to training and immune health can be observed without sophisticated assays. An athlete may improve a deadlift while also experiencing hypertension, sleep apnea, or other conditions requiring separate attention. Another may have an ordinary viral illness despite well-designed programming. Neither situation can be solved by arbitrarily changing set counts to repair an imaginary immune system. Mature performance culture evaluates sporting outcomes and health together while recognizing that the indicators do not always coincide. This is where immunology becomes useful: it expands our view of the organism without reducing a person to one laboratory figure.

Interpreting biomarkers without inventing diagnoses

A complete blood count describes leukocyte numbers and certain cellular categories but does not directly test every aspect of antimicrobial defense. A blood result collected after exertion can show transient leukocytosis without necessarily indicating bacterial infection. Conversely, persistent abnormalities accompanied by symptoms warrant clinical assessment. Interpretation depends on absolute counts, previous measurements, collection timing, treatments, and examination. In a sports journal, noting whether blood was sampled 12 or 48 hours after a demanding session is sensible. Turning neutrophil counts into an automatic training-volume prescription or a verdict on competition readiness is not. Laboratory tests have indications and limitations; using them without context can generate needless alarm and false reassurance alike.

C-reactive protein, or CRP, is an acute-phase marker whose concentration can increase in various inflammatory settings. Clinicians interpret it alongside history and other examinations, but one value alone does not identify the cause or location of inflammation. Around demanding exercise or tissue injury, chronology matters for interpreting an inflammatory marker. Equally, CRP within a reference range cannot exclude every clinical condition. Resistance-training research has produced non-uniform CRP results, illustrating the relevance of intervention duration, population, and methods. There is no universal CRP threshold that establishes whether an athlete is ready to lift a 150-kilogram Atlas stone [11].

Creatine kinase, abbreviated CK, is often discussed in strength sports because levels can rise after demanding muscular work. However, CK is not a specific marker of immune function and does not show directly how effectively the body responds to viruses. It is influenced by muscle mass, exercise type, individual responsiveness, and sampling time. Some athletes experience substantial elevations after unfamiliar exercise, whereas others display smaller variations. One abnormal result cannot automatically diagnose rhabdomyolysis; on the other hand, severe muscular pain, pronounced weakness, and dark urine require urgent assessment. Confusing markers of muscle disturbance with immune indicators can produce misleading conclusions about both health and programming [6].

Interleukines measured in research laboratories present further challenges. Concentrations can be low, analytical methods vary, and reference ranges are not universally standardized for athletes performing maximal events. More importantly, identifying a statistical change does not automatically establish its clinical consequences. An increase in IL-6 after training must be interpreted in the context of baseline status, collection conditions, other signals, and the research question. Treating every cytokine as a position on a scale from good to bad is mistaken. Inflammation involves networks of amplification, limitation, and resolution. Data can be excellent for investigating mechanisms yet inadequate for guiding everyday athlete decisions without medical context [5,10].

Some studies use flow cytometry to identify lymphocyte subsets through surface markers. This approach distinguishes phenotypes that a routine blood count cannot show, but interpretation depends on antibody panels, gating strategies, and quality control. A cellular phenotype alone does not establish whether the response to a pathogen is appropriate. Other investigations test phagocytosis, mediator secretion, or proliferation under experimental conditions. These techniques offer different windows into biological mechanisms rather than perfectly interchangeable scores. Two investigations can therefore report different results without one necessarily being false: they may be examining distinct components of the same complicated system [4].

A measurement is useful to the extent that it answers a specific question. Diagnosing respiratory infection calls for clinical history, examination, and occasionally pathogen-specific tests rather than an experimental cytokine panel. Investigating post-exercise lymphocyte traffic may require serial sampling and identification of cellular subsets. Assessing an athlete's overall health may demand attention to blood pressure, metabolic status, sleep, and medical history even though these are not immune tests. Research and clinical practice sometimes share instruments but pursue different aims. Choosing the wrong test for the right question is a major source of confusion in sports discussions.

Three strongman situations and their proper interpretation

The first scenario is a heavy deadlift session with few repetitions and long rests. The athlete leaves the gym tired but has no fever, respiratory complaints, or marked loss of muscular function. Blood collected immediately might reveal temporary leukocyte changes, yet these should be interpreted cautiously as exercise-associated mobilization rather than presumed infection. Clinical conclusions cannot be drawn solely from fatigue and a blood result. Longitudinal patterns, symptoms, and independent health evaluation matter. The scenario proves neither that heavy lifting protects immunity nor that it necessarily produces a window of vulnerability. It illustrates the distinction between an acute physiological response and the diagnosis of disease.

The second scenario involves a weekend containing yoke, farmers walks, log press, and loading events. The athlete spends hours in a crowded venue, sleeps less than usual, and travels after the final event. Two days later, a sore throat develops. Possible explanations include infection acquired before or during the event, airway irritation, allergy, or another condition. The claim that the log event suppressed immunity is unproven. Moving forward would require symptom chronology, clinical assessment where appropriate, and information about exposure. From a prevention perspective, hygiene, contact management, and travel planning make sense even when the athlete's precise molecular mechanisms remain unknown. The problem is multifactorial, just as the specialist literature emphasizes [3,12].

The third scenario is an extended preparation block in which performance stagnates, sleep remains inadequate, appetite declines, and repeated symptom episodes occur. This warrants review of workload, health, and living conditions; it does not justify automatic diagnosis of collapsed immunity or overtraining. Overtraining syndrome is a complex condition requiring appropriate evaluation and exclusion of other causes, not a synonym for a difficult week. Infection, inadequate intake, sleep disorders, or other conditions may be present. A reasonable response is structured assessment, load reduction when indicated, and medical review for persistent symptoms instead of an arbitrary immune-reset protocol.

These cases show why observation and causation must remain distinct. An athlete can record events accurately yet infer the wrong mechanism behind them. The event was demanding, fatigue followed, and a viral illness appeared: that chronology alone does not identify the pathway. Conversely, not developing an illness does not prove that training produced no immune-related response. A researcher would ask what would have occurred under comparable conditions without that stimulus, but such a counterfactual cannot be directly observed for the same person. Control groups and longitudinal designs attempt to approximate it. In everyday coaching, careful documentation and proportionate decisions remain more useful than hindsight certainty.

An applied training journal should not become an imaginary laboratory

A training journal can record date, event type, approximate volume, perceived difficulty, session duration, and any symptoms. Notes about sleep, travel, environmental conditions, and major dietary changes also help place health observations in context. The aim is not obsessive collection of every variable but a verifiable record when a problem arises. If an athlete notices feeling unwell after multiple weekends involving extensive travel, that is a hypothesis for future planning, not proof of impaired lymphocyte function. A good journal separates objective measurements from subjective experience and from later interpretation. Distinct fields for symptom, possible contributor, and subsequent action help prevent facts from being confused with assumptions.

For periodic monitoring, consistency is often more valuable than unnecessary complexity. Evaluations performed at comparable times and conditions and viewed against personal history may be more informative than irregular measurement of numerous biomarkers. Even well-standardized routine blood tests, however, do not validate a personal algorithm for predicting colds. A period without symptoms is encouraging but does not guarantee protection for future competitions. Health-data confidentiality matters too: within a team, personal medical information should not become a public immunity ranking or a reason for pressure on athletes.

For a coach, an operational question is whether the athlete is in suitable condition for the planned stimulus. This is assessed through performance, fatigue, symptoms, and context rather than assuming that every post-exercise variation is hazardous. Fever, breathing difficulty, chest pain, palpitations, or significant systemic illness shift attention from performance optimization to medical assessment. The Olympic consensus on respiratory infections recommends a structured approach to return-to-sport decisions, including attention to symptoms and the response to exercise. Such decisions must be individualized and cannot be replaced by an informal test of maximal strength [12].

A responsible team can schedule heavy exposures, avoid accidental clustering of high-volume days, and account for practical resources. This is not a specialized immune protocol but a normal application of workload-management principles. When competition involves several days of events, food, accommodation, sleep, and travel are elements of preparation. When respiratory symptoms arise, participation decisions should consider the athlete and other people's health. Incomplete understanding of every molecular mechanism does not prevent the use of sound health principles. Scientific uncertainty is not the same as absence of practical responsibility.

For a broad readership, the message is straightforward: movement matters for health, but even the strongest athlete remains susceptible to infection. Well-tolerated strength training should not be portrayed as an inevitable attack on the body, while extraordinary performance does not eliminate the need for prevention, sleep, and medical care. The organism does not choose between exertion and immunity as separate switches. It integrates simultaneous signals, with outcomes shaped by dose, history, and the surrounding environment. That perspective may be less spectacular than marketing promises, but it is much more useful for durable decisions.

What makes immunological evidence convincing?

Scientific evidence differs not merely in the prestige of the journal but in the question asked, the method chosen, and the ability to control alternative explanations. An acute experiment can rigorously describe what happens to selected cells in the two hours after a workout; without additional data, it cannot establish whether the same people will experience fewer infections in the following year. An observational study may follow large populations and discover associations between activity and health, but it remains vulnerable to confounding. A randomized trial can test an intervention, yet may be too small or too short to observe uncommon clinical events. A systematic review collects available evidence but does not magically convert weak experiments into certainty. Credible conclusions in exercise immunology emerge from methods that converge while retaining the limitations of each approach [1–4].

Statistical significance by itself does not reveal how important a difference is to an athlete. A p value is influenced by the observations, variability, and sample size; it is not simply the probability that the underlying hypothesis is true. Confidence intervals can help assess precision, while effect sizes convey the average magnitude of change. In an experiment measuring a cytokine, a statistically detectable difference may have no demonstrated clinical consequences. In another investigation, a nonsignificant result may reflect an inadequate sample rather than the complete absence of an effect. Readers need to distinguish these situations before transforming a research abstract into a universal recommendation. Saying that studies show something without specifying which studies and which outcomes were measured is inadequate for a serious scientific claim.

A further challenge is the number of outcomes measured simultaneously. If a researcher investigates twenty cytokines, five immune-cell populations, and multiple collection times, chance findings become more likely unless statistical analysis is planned appropriately. Selective publication of striking results may reinforce the impression of dramatic effects. Readers of sports research should ask whether the primary outcome was specified beforehand, whether analytical methods are transparent, and whether null results are acknowledged. When one study emphasizes the increase in a particular molecule while ignoring the rest of the data, a broad conclusion of improved immunity requires caution. Rigor does not mean dismissing results; it means giving every result a weight proportional to what it actually establishes.

Sport specificity is especially important for this series. Cycle-ergometer interventions can control duration and oxygen consumption precisely, yet they cannot reproduce all the demands of a heavy Atlas stone. Leg-press training among older adults may reveal an effect on selected cellular functions without validating the competitive programming of an Open-class strength athlete. Realistic strongman research would need to describe the event distribution, training experience, body characteristics, medical condition, and workload while preserving enough standardization for interpretation. Direct studies would benefit from collaboration among athletes, coaches, laboratory specialists, and sports physicians. Until that evidence exists, the best recommendations will combine clearly labeled extrapolations with established medical principles, without disproportionate promises.

Causality also requires a view of training dose. Dose is not merely the arithmetic product of sets and repetitions: internal load concerns what the organism actually experiences, whereas external load describes observable work. Two people performing the same farmers-carry distance may face very different relative demands because their capacities, technique, and starting conditions differ. Good immunological investigations would report both external context and individual responses without converting subjective ratings into molecular evidence. An athlete's unusually high perceived exertion deserves attention; it does not allow the level of an interleukin to be estimated from that sensation.

A good explanation can be tested through predictions that might turn out to be false. For example, the assertion that any cortisol increase produces infection should predict repeatable clinical outcomes after similar brief elevations; actual evidence is much more complicated. Likewise, claiming that resistance exercise always strengthens immunity requires specifying which function improves, in whom, and over what period. Without such detail, the statement is not a testable hypothesis but promotional language. Science is valuable not because it offers certainty on every topic but because its claims can be corrected as new evidence arrives. In a highly visible sport such as strongman, intellectual transparency is a form of respect for athletes and readers.

What can we apply without claiming more than we know?

The first application is rational exercise dosing. Effective programming delivers sessions suited to sporting objectives, adjusting load to performance, experience, and tolerance. It does not guarantee the absence of infections, but reduces perpetual improvisation and helps identify meaningful change. The second is respect for general health measures: hygiene, adequate nutrition, sleep, exposure management, and access to appropriate clinical care. The third is cautious laboratory interpretation: important results should be discussed with a professional, cannot replace clinical observations, and should not motivate improvised immune treatments. These principles may sound less exciting than supplement advertisements, but they rest on sound biological and practical reasoning [2,12].

Before competition, useful decisions are often logistical. Athletes can organize meals, transport, available sleep time, and equipment so that avoidable stressors do not accumulate unnecessarily. These steps cannot eliminate all risk of illness, yet they may preserve conditions under which the body functions normally. A contest preceded by excellent physical preparation but poorly organized travel illustrates why performance is not confined to gym sessions. Immunological thinking makes such relationships visible without assigning an experimentally proven cellular effect to every travel detail. The principles matter to advanced competitors and recreational lifters alike.

During an illness episode, priorities change. Fever, systemic symptoms, chest discomfort, breathing difficulty, palpitations, or disproportionate malaise warrant medical assessment and avoiding the impulse to attempt maximal training. Return following infection should be individualized according to severity, progression, and clinical advice. In the Olympic consensus, symptom reassessment and tolerance of modest activity form part of structured decision making; this is not an invitation to self-test under exceptionally heavy implements. Particularly after an illness with systemic manifestations, attempting a personal record is not an appropriate test of recovery. Health makes long-term athletic performance possible, not the reverse [12].

Protection against infection must not be confused with a permanent absence of inflammation. Defense against microbes involves inflammatory responses under certain conditions, and proper regulation is an essential part of health. Someone seeking to block every rise in a cytokine may be pursuing a biologically misguided target. Conversely, preventing and treating chronic inflammatory disease requires medical assessment and attention to relevant causes. This episode does not promise one marker of perfect balance. It offers a framework in which every signal is judged by function, anatomical compartment, duration, and clinical consequences. That framework can guide later installments addressing innate immunity, adaptive memory, and muscle-derived mediators separately.

Coaches play a particularly important role because they interact with athletes daily, but their responsibilities are not identical to those of physicians. Coaches can notice performance changes, adjust workloads, advise rest when an athlete is ill, and encourage medical consultation. They are not expected to diagnose immunodeficiency from pulse rate, skin appearance, or completed repetitions. Collaboration with sports medicine and other appropriate specialists allows gym-based knowledge to be integrated with clinical assessment. Professional boundaries between fields strengthen athlete autonomy by providing better information and clarifying responsibility.

Researchers interested in strongman have a realistic agenda of unanswered questions. How does leukocyte trafficking differ after a maximal single compared with a prolonged medley? What roles do rest intervals and engaged muscle mass play? How does previous training modify responses from one week to the next? Can confirmed infections be documented prospectively alongside social exposures and sleep? What distinguishes one-day competitions from events held over several days? These questions do not require invented answers to be worthwhile. Careful formulation can instead support stronger protocols, inter-club collaboration, and more responsible public interpretation.

Conceptually, the best picture is of a network that temporarily reallocates its resources. During exertion, muscles, blood vessels, neural circuits, and immune cells respond to immediate requirements. Afterward, some changes subside while others continue through signaling and regulatory processes. Repeated training under suitable conditions may yield longer-term adaptations, but their direction and magnitude cannot be compressed into a marketing label. Infection risk simultaneously depends on the microorganism, exposure, and host. This layered organization explains the apparent contradiction between fast cellular changes and clinical health: they concern different phenomena that are related but not identical.

Maintaining intellectual discipline requires four questions for every applied claim: what was measured, in whom, when, and with what meaningful outcome? If a study measured IL-6 after squats, it did not necessarily measure infections after an Atlas-stone contest. If a cohort linked physical activity with health, it did not necessarily demonstrate the mechanism of an individual exercise. If an investigation documented changes in older adults, applying the results to the Open category remains a hypothesis, not a certainty. These qualifications do not reduce the value of research; they allow its recommendations to be correctly bounded. A sport that quantifies performance so precisely in kilograms deserves equal precision when discussing the biology underlying strength.

Conclusion: host defense is a dynamic function, not a trophy

The immune system and skeletal muscle are not separate institutions. Strength exertion mobilizes neural and endocrine signals, changes circulating immune-cell distributions, influences molecular mediators, and may contribute to longer-term adaptation through repetition. These changes alone prove neither enhanced immunity nor immune suppression. Strongman-specific data are more limited than research on general exercise and conventional resistance training, and interpretation should acknowledge that distinction. The strongest conclusions concern the integrated nature of the response and the need to separate biomarkers from clinical infections. An athlete may possess extraordinary strength and still need appropriate vaccination, prevention, medical evaluation, and recovery. Understanding mechanisms does not abolish human vulnerability; it supplies tools for making better decisions [1–4,12].

This opening episode establishes the vocabulary and limits of the series. Subsequent installments will examine innate defense, adaptive memory, myokines, physiological inflammation, respiratory infections, multi-day competitions, vaccination, return after illness, and immune-health monitoring, without attributing unwarranted certainty to individual findings. For athletes, the central lesson is simple: intelligent preparation pursues performance and health together, and biology should be read precisely rather than turned into a collection of slogans. Strength is visible on the platform; the body's defense is built and regulated through processes far more complex than a single lift.

Selected scientific bibliography

[1] Campbell, J. P., & Turner, J. E. (2018). Debunking the Myth of Exercise-Induced Immune Suppression: Redefining the Impact of Exercise on Immunological Health Across the Lifespan. Frontiers in Immunology, 9, 648. DOI: 10.3389/fimmu.2018.00648. https://doi.org/10.3389/fimmu.2018.00648

[2] Nieman, D. C., & Wentz, L. M. (2019). The compelling link between physical activity and the body's defense system. Journal of Sport and Health Science, 8(3), 201–217. DOI: 10.1016/j.jshs.2018.09.009. https://doi.org/10.1016/j.jshs.2018.09.009

[3] Simpson, R. J., Campbell, J. P., Gleeson, M., et al. (2020). Can exercise affect immune function to increase susceptibility to infection? Exercise Immunology Review, 26, 8–22. PMID: 32139352. https://pubmed.ncbi.nlm.nih.gov/32139352/

[4] Salimans, L., Liberman, K., Njemini, R., et al. (2022). The effect of resistance exercise on the immune cell function in humans: A systematic review. Experimental Gerontology, 164, 111822. DOI: 10.1016/j.exger.2022.111822. https://doi.org/10.1016/j.exger.2022.111822

[5] Pedersen, B. K., & Febbraio, M. A. (2008). Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiological Reviews, 88(4), 1379–1406. DOI: 10.1152/physrev.90100.2007. https://doi.org/10.1152/physrev.90100.2007

[6] Peake, J. M., Neubauer, O., Della Gatta, P. A., & Nosaka, K. (2017). Muscle damage and inflammation during recovery from exercise. Journal of Applied Physiology, 122(3), 559–570. DOI: 10.1152/japplphysiol.00971.2016. https://doi.org/10.1152/japplphysiol.00971.2016

[7] Peake, J. M., Neubauer, O., Walsh, N. P., & Simpson, R. J. (2017). Recovery of the immune system after exercise. Journal of Applied Physiology, 122(5), 1077–1087. DOI: 10.1152/japplphysiol.00622.2016. https://doi.org/10.1152/japplphysiol.00622.2016

[8] Dhabhar, F. S. (2014). Effects of stress on immune function: the good, the bad, and the beautiful. Immunologic Research, 58, 193–210. DOI: 10.1007/s12026-014-8517-0. https://doi.org/10.1007/s12026-014-8517-0

[9] Simpson, R. J., et al. (2021). Exercise and adrenergic regulation of immunity. Brain, Behavior, and Immunity. DOI: 10.1016/j.bbi.2021.07.010. https://doi.org/10.1016/j.bbi.2021.07.010

[10] Ringleb, et al. (2024). Beyond muscles: Investigating immunoregulatory myokines in acute resistance exercise: A systematic review and meta-analysis. The FASEB Journal, 38, e23596. DOI: 10.1096/fj.202301619R. https://doi.org/10.1096/fj.202301619R

[11] Effect of resistance exercise on peripheral inflammatory biomarkers in healthy adults: a meta-analysis of randomized controlled trials (2022). PMID: 36394722. https://pubmed.ncbi.nlm.nih.gov/36394722/

[12] Schwellnus, M., et al. (2022). International Olympic Committee (IOC) consensus statement on acute respiratory illness in athletes, part 1: acute respiratory infections. British Journal of Sports Medicine, 56, 1066–1088. DOI: 10.1136/bjsports-2022-105759. https://doi.org/10.1136/bjsports-2022-105759